
USD
+$0.00
(+0.00%
)At Close (As of Oct 24, 2025)
$157.52B
Market Cap
45.89
P/E Ratio
4.86
EPS
$256.97
52 Week High
$170.43
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $14B |
| Total Revenue | $24B |
| Cost Of Revenue | $9.7B |
| Costof Goods And Services Sold | $9.7B |
| Operating Income | $5.2B |
| Selling General And Administrative | $7.8B |
| Research And Development | $1.6B |
| Operating Expenses | $9B |
| Investment Income Net | - |
| Net Interest Income | -$161M |
| Interest Income | $117M |
| Interest Expense | $278M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.4B |
| Income Before Tax | $4.6B |
| Income Tax Expense | $747M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $3.9B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $4.9B |
| Ebitda | $7.3B |
| Net Income | $3.9B |
| Field | Value (USD) |
|---|---|
| Total Assets | $78B |
| Total Current Assets | $9.5B |
| Cash And Cash Equivalents At Carrying Value | $2.1B |
| Cash And Short Term Investments | $2.1B |
| Inventory | $2.3B |
| Current Net Receivables | $4.4B |
| Total Non Current Assets | $68B |
| Property Plant Equipment | $6.1B |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $19B |
| Intangible Assets Excluding Goodwill | $19B |
| Goodwill | $40B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $699M |
| Other Non Current Assets | - |
| Total Liabilities | $28B |
| Total Current Liabilities | $6.8B |
| Current Accounts Payable | $1.8B |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $678M |
| Total Non Current Liabilities | $21B |
| Capital Lease Obligations | $1.1B |
| Long Term Debt | $16B |
| Current Long Term Debt | $505M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $17B |
| Other Current Liabilities | $3.1B |
| Other Non Current Liabilities | $214M |
| Total Shareholder Equity | $50B |
| Treasury Stock | - |
| Retained Earnings | $44B |
| Common Stock | $9M |
| Common Stock Shares Outstanding | $737M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $6.7B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $2.4B |
| Capital Expenditures | $1.4B |
| Change In Receivables | - |
| Change In Inventory | $147M |
| Profit Loss | - |
| Cashflow From Investment | -$2B |
| Cashflow From Financing | -$8.4B |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $768M |
| Dividend Payout Common Stock | $768M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$6B |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $3.9B |
| Field | Value (USD) |
|---|---|
| Gross Profit | $14B |
| Total Revenue | $24B |
| Cost Of Revenue | $9.7B |
| Costof Goods And Services Sold | $9.7B |
| Operating Income | $5.2B |
| Selling General And Administrative | $7.8B |
| Research And Development | $1.6B |
| Operating Expenses | $9B |
| Investment Income Net | - |
| Net Interest Income | -$161M |
| Interest Income | $117M |
| Interest Expense | $278M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.4B |
| Income Before Tax | $4.6B |
| Income Tax Expense | $747M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $3.9B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $4.9B |
| Ebitda | $7.3B |
| Net Income | $3.9B |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-09-26 |
| Declaration Date | 2025-09-09 |
| Record Date | 2025-09-26 |
| Payment Date | 2025-10-31 |
| Amount | 0.32 |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Danaher Corporation is a prominent American diversified conglomerate based in Washington, D.C., recognized for its cutting-edge innovations across multiple sectors, including Life Sciences, Diagnostics, and Environmental & Applied Solutions. The company employs advanced technologies to advance healthcare and improve efficiencies in industrial processes worldwide, demonstrating a strong commitment to enhancing patient outcomes and operational performance. With a diverse portfolio of scientific and diagnostic products, Danaher maintains a leadership position in the global market, poised for continued growth and impact across its core sectors.